Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Neurologia (Barcelona, Spain)|April 15, 2010
[New mutation in the PSEN1 (E120G) gene associated with early onset Alzheimer's disease]A Lladó, R Sánchez-Valle, M J Rey, et al.
European Journal of Neurology|February 18, 2010
A novel PSEN1 mutation (K239N) associated with Alzheimer's disease with wide range age of onset and slow progressionA Lladó, J Fortea, T Ojea, et al.
Cephalalgia : an International Journal of Headache|February 26, 2008
Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptanP J Goadsby, G Zanchin, G Geraud, et al.
Neurologia (Barcelona, Spain)|December 18, 2010
PICOGEN: five years experience with a genetic counselling program for dementiaJ Fortea, A Lladó, J Clarimón, et al.
Osteoarthritis and Cartilage|March 28, 2007
Aceclofenac vs paracetamol in the management of symptomatic osteoarthritis of the knee: a double-blind 6-week randomized controlled trialE Batlle-Gualda, J Román Ivorra, E Martín-Mola, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 24, 2025
Potential of facial biomarkers for Alzheimer's disease and obstructive sleep apnea in Down syndrome and general populationL M Echeverry-Quiceno, S Llambrich, Á Heredia-Lidón, et al.
Translational Psychiatry|December 5, 2013
Loss of serum IGF-I input to the brain as an early biomarker of disease onset in Alzheimer miceA Trueba-Sáiz, C Cavada, A M Fernandez, et al.
Alimentary Pharmacology & Therapeutics|November 3, 2012
Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpointsE M M Quigley, J Tack, W D Chey, et al.
Medicina Clinica|February 23, 1999
[Haemophilus influenzae type b invasive disease in Catalonia (1996)]A Domínguez, C Latorre, V Pineda, et al.
Scientific Reports|June 10, 2020
Differential levels of Neurofilament Light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disordersC Delaby, D Alcolea, M Carmona-Iragui, et al.
Pageof 2